GlycoNexGlycoNex
  • About Us
  • News
  • Glycan-targeted technology​​
  • Services
  • Pipeline
  • Investors
    • Financials
    • Shareholder Services
    • Corporate Governance
    • Investor Conference
    • Share Transfer Agency and Spokesman
      • English (United States)
      • 中文(繁體．台灣)

NEWS

2025-12-08 GlycoNex Signs CDMO Service Agreement with Change Cure to Advance HMGB1-Targeted Antibody Program
2025-12-08 GlycoNex Signs CDMO Service Agreement with Change Cure to Advance HMGB1-Targeted Antibody Program
Read More
2025-11-20 GlycoNex and Hokkaido University Hospital Launch Study to Advance Glycan-Directed ADC Development in Gastric Cancer
2025-11-20 GlycoNex and Hokkaido University Hospital Launch Study to Advance Glycan-Directed ADC Development in Gastric Cancer
Read More
2025-10-20 GlycoNex Abstract on Glycan-Directed ADC GNX1021 Accepted for Presentation at AACR-NCI-EORTC 2025
2025-10-20 GlycoNex Abstract on Glycan-Directed ADC GNX1021 Accepted for Presentation at AACR-NCI-EORTC 2025
Read More
See All News
Tel
+ (886) 2-2697-4168
Fax
+ (886) 2-2697-1168
+ (886) 2-2697-5168
Email
mail@glyconex.com.tw
Join us
104徵才網站
Address
8F., No.97, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City 221, Taiwan
  • About Us
  • News
  • Glycan-targeted technology​​
  • Services
  • Pipeline
  • Investors
    • Financials
    • Shareholder Services
    • Corporate Governance
    • Investor Conference
    • Share Transfer Agency and Spokesman
  • Search Icon
  • language
    • 中文
    • English